Literature DB >> 10500146

Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation.

P Sharma1, M Sharma, N D Amin, R W Albers, H C Pant.   

Abstract

Cyclin-dependent kinase 5 (cdk5) is found in an active form only in neuronal cells. Activation by virtue of association with the cyclin-like neuronal proteins p35 (or its truncated form p25) and p39 is the only mechanism currently shown to regulate cdk5 catalytic activity. In addition to cyclin binding, other members of the cdk family require for maximal activation phosphorylation of a Ser/Thr residue (Thr(160) in the case of cdk-2) that is conserved in all cdks except cdk8. This site is phosphorylated by cdk-activating kinases, which, however, do not phosphorylate cdk5. To examine the possible existence of a phosphorylation-dependent regulatory mechanism in the case of cdk5, we have metabolically labeled PC12 cells with (32)P(i) and shown that the endogenous cdk5 is phosphorylated. Bacterially expressed cdk5 also can be phosphorylated by PC12 cell lysates. Phosphorylation of cdk5 by a PC12 cell lysate results in a significant increase in cdk5/p25 catalytic activity. Ser(159) in cdk5 is homologous to the regulatory Thr(160) in cdk2. A Ser(159)-to-Ala (S159A) cdk5 mutant did not show similar activation, which suggests that cdk5 is also regulated by phosphorylation at this site. Like other members of the cdk family, cdk5 catalytic activity is influenced by both p25 binding and phosphorylation. We show that the cdk5-activating kinase (cdk5AK) is distinct from the cdk-activating kinase (cyclin H/cdk7) that was reported previously to neither phosphorylate cdk5 nor affect its activity. We also show that casein kinase I, but not casein kinase II, can phosphorylate and activate cdk5 in vitro.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10500146      PMCID: PMC18003          DOI: 10.1073/pnas.96.20.11156

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Statistical analysis of protein kinase specificity determinants.

Authors:  A Kreegipuu; N Blom; S Brunak; J Järv
Journal:  FEBS Lett       Date:  1998-06-23       Impact factor: 4.124

2.  cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization.

Authors:  K T Shetty; W T Link; H C Pant
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

3.  CDK-5-mediated neurofilament phosphorylation in SHSY5Y human neuroblastoma cells.

Authors:  M Sharma; P Sharma; H C Pant
Journal:  J Neurochem       Date:  1999-07       Impact factor: 5.372

4.  p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5.

Authors:  L H Tsai; I Delalle; V S Caviness; T Chae; E Harlow
Journal:  Nature       Date:  1994-09-29       Impact factor: 49.962

5.  Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments.

Authors:  H K Paudel; J Lew; Z Ali; J H Wang
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

6.  Activation of human cyclin-dependent kinases in vitro.

Authors:  D Desai; Y Gu; D O Morgan
Journal:  Mol Biol Cell       Date:  1992-05       Impact factor: 4.138

7.  Phosphorylation of synthetic fragments of inhibitor-2 of protein phosphatase-1 by casein kinase-1 and -2. Evidence that phosphorylated residues are not strictly required for efficient targeting by casein kinase-1.

Authors:  O Marin; F Meggio; S Sarno; M Andretta; L A Pinna
Journal:  Eur J Biochem       Date:  1994-07-15

8.  Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression.

Authors:  M R Hellmich; H C Pant; E Wada; J F Battey
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

9.  Bovine neurofilament-enriched preparations contain kinase activity similar to casein kinase I--neurofilament phosphorylation by casein kinase I (CKI).

Authors:  W T Link; A Dosemeci; C C Floyd; H C Pant
Journal:  Neurosci Lett       Date:  1993-03-05       Impact factor: 3.046

10.  Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase.

Authors:  J Y Kato; M Matsuoka; D K Strom; C J Sherr
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

View more
  38 in total

1.  Identification and characterization of a novel phosphoregulatory site on cyclin-dependent kinase 5.

Authors:  Brett Lee Roach; Jordan Matthew Ngo; Clariss Limso; Koyinsola Bolutife Oloja; Deepali Bhandari
Journal:  Biochem Biophys Res Commun       Date:  2018-09-11       Impact factor: 3.575

2.  Structural and dynamic determinants of ligand binding and regulation of cyclin-dependent kinase 5 by pathological activator p25 and inhibitory peptide CIP.

Authors:  A Cardone; S A Hassan; R W Albers; R D Sriram; H C Pant
Journal:  J Mol Biol       Date:  2010-06-25       Impact factor: 5.469

3.  Cyclin-dependent kinase 5 regulates degranulation in human eosinophils.

Authors:  Solomon O Odemuyiwa; Ramses Ilarraza; Francis Davoine; Michael R Logan; Anooshirvan Shayeganpour; Yingqi Wu; Carina Majaesic; Darryl J Adamko; Redwan Moqbel; Paige Lacy
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

4.  Phosphorylation of targeting protein for Xenopus kinesin-like protein 2 (TPX2) at threonine 72 in spindle assembly.

Authors:  Su Yeon Shim; Ignacio Perez de Castro; Gernot Neumayer; Jian Wang; Sang Ki Park; Kamon Sanada; Minh Dang Nguyen
Journal:  J Biol Chem       Date:  2015-02-16       Impact factor: 5.157

Review 5.  Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D).

Authors:  Pengfei Xu; Chiara Ianes; Fabian Gärtner; Congxing Liu; Timo Burster; Vasiliy Bakulev; Najma Rachidi; Uwe Knippschild; Joachim Bischof
Journal:  Gene       Date:  2019-07-31       Impact factor: 3.688

6.  Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.

Authors:  Yun Ding; Aimin Qiao; Ziqing Wang; J Shawn Goodwin; Eun-Sook Lee; Michelle L Block; Matthew Allsbrook; Michael P McDonald; Guo-Huang Fan
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

Review 7.  Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders.

Authors:  Aidong Yuan; Ralph A Nixon
Journal:  Brain Res Bull       Date:  2016-09-05       Impact factor: 4.077

8.  Neuronal cyclin-dependent kinase 5 activity is critical for survival.

Authors:  T Tanaka; T Ohshima; P Rajan; N D Amin; A Cho; T Sreenath; H C Pant; R O Brady; A B Kulkarni
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

9.  Regulation of Kalirin by Cdk5.

Authors:  Xiaonan Xin; Yanping Wang; Xin-ming Ma; Panteleimon Rompolas; Henry T Keutmann; Richard E Mains; Betty A Eipper
Journal:  J Cell Sci       Date:  2008-07-15       Impact factor: 5.285

10.  Identification of non-muscle myosin heavy chain as a substrate for Cdk5 and tool for drug screening.

Authors:  Anne Jämsä; Karin Agerman; Ann-Cathrin Radesäter; Jan Ottervald; Jonas Malmström; Gösta Hiller; Gang Liu; Mervi Vasänge
Journal:  J Biomed Sci       Date:  2009-06-17       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.